Turner MC, et al. - The impact of delayed chemotherapy on overall survival across multiple time points in stage III colon cancer was determined. It was observed that for maximal benefit, patients should receive adjuvant chemotherapy within 6-8 weeks following resection of stage III colon cancer. However, it was recommended that chemotherapy be offered to patients who are outside the optimal window, who have significant co-morbidities, or who have had a complication >24 weeks from resection to improve the overall survival when compared to omitting chemotherapy.